Amicus Therapeutics Stock (NASDAQ: FOLD) stock price, news, charts, stock research, profile.
Open | $10.700 |
Close | $10.820 |
Volume / Avg. | 4.621M / 3.047M |
Day Range | 10.660 - 10.910 |
52 Wk Range | 9.700 - 14.570 |
Market Cap | $3.196B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 45 |
Short Interest | 11.05% |
Days to Cover | 13.81 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Amicus Therapeutics (NASDAQ: FOLD) through any online brokerage.
Other companies in Amicus Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), IDEAYA Biosciences (NASDAQ:IDYA), Ultragenyx Pharmaceutical (NASDAQ:RARE), MoonLake (NASDAQ:MLTX) and Alkermes (NASDAQ:ALKS).
The latest price target for Amicus Therapeutics (NASDAQ: FOLD) was reported by JP Morgan on Monday, March 18, 2024. The analyst firm set a price target for 19.00 expecting FOLD to rise to within 12 months (a possible 75.60% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Amicus Therapeutics (NASDAQ: FOLD) is $10.82 last updated April 22, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Amicus Therapeutics.
Amicus Therapeutics’s Q1 earnings are confirmed for Wednesday, May 8, 2024.
There is no upcoming split for Amicus Therapeutics.
Amicus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.